M. Mello

发表

Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors

D. Olive, B. Malissen, J. Nunès, 2022, bioRxiv.

Brucella β 1,2 Cyclic Glucan Is an Activator of Human and Mouse Dendritic Cells

E. Klechevsky, J. Banchereau, Anna R Martirosyan, 2012, PLoS pathogens.

Disrupted Lymph Node and Splenic Stroma in Mice with Induced Inflammatory Melanomas Is Associated with Impaired Recruitment of T and Dendritic Cells

L. Leserman, S. Henri, B. J. Van den Eynde, 2011, PloS one.

current as Cells p 38 MAPK in Cross-Presenting Dendritic Peripheral Deletion of CD 8 T Cells Requires and Grégory

B. Lu, L. Sherman, Trevor R. F. Smith, 2017 .

Increasing the Number of Thyroid Lesions Classes in Microarray Analysis Improves the Relevance of Diagnostic Markers

R. Houlgatte, Jean-Fred Fontaine, B. Franc, 2009, PloS one.

Conditional Deletion of Pdcd1 Identifies the Cell-Intrinsic Action of PD-1 on Functional CD8 T Cell Subsets for Antitumor Efficacy

R. de Waal Malefyt, T. Rosahl, H. Luche, 2021, Frontiers in immunology.

Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors

D. Olive, B. Malissen, J. Nunès, 2023, Journal for ImmunoTherapy of Cancer.

Peripheral Deletion of CD8 T Cells Requires p38 MAPK in Cross-Presenting Dendritic Cells

B. Lu, L. Sherman, Trevor R. F. Smith, 2017, The Journal of Immunology.